RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 NGS Genetic DNA Test
Introduction
The RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 NGS Genetic DNA Test is a pivotal diagnostic tool designed to identify genetic mutations associated with an increased risk of breast and ovarian cancer. Understanding your genetic predisposition can empower you and your family to take proactive health measures.
What the Test Measures
This test specifically measures mutations in the RAD51D gene, which plays a vital role in DNA repair. Mutations in this gene can significantly elevate the risk of developing breast and ovarian cancers, particularly in individuals with a familial history of these diseases.
Who Should Consider This Test?
Individuals with a family history of breast or ovarian cancer, especially those who have close relatives diagnosed with these conditions, should consider this test. Symptoms that may warrant testing include:
- Family history of breast or ovarian cancer
- Early onset of breast cancer in family members
- Multiple cases of breast or ovarian cancer in the family
Benefits of Taking the Test
- Identifies genetic risks that may affect you and your family.
- Enables informed decisions regarding preventive measures and surveillance strategies.
- Facilitates personalized treatment plans if a mutation is detected.
- Provides peace of mind for those concerned about their cancer risk.
Understanding Your Results
Results from the RAD51D Gene test will indicate whether a mutation is present. A positive result suggests a higher risk of breast and ovarian cancer, allowing for a discussion with your healthcare provider about potential preventive measures. A negative result may provide reassurance but does not eliminate the risk entirely.
Test Information and Pricing
Test Name | RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 NGS Genetic DNA Test |
---|---|
Discount Price | 400000 NGN |
Regular Price | 560000 NGN |
Booking the Test
To book the RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility to Type 4 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you in scheduling your appointment and answering any questions you may have.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One Drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with RAD51D gene-related breast-ovarian cancer.
Consult with an oncologist or genetics specialist to understand the implications of your test results and to discuss potential next steps for your health.